Explore the words cloud of the CandidaHunter project. It provides you a very rough idea of what is the project "CandidaHunter" about.
The following table provides information about the project.
MATRIKS BIYOTEKNOLOJI SANAYI VE TICARET LIMITED SIRKETI
|Coordinator Country||Turkey [TR]|
|Total cost||71˙429 €|
|EC max contribution||50˙000 € (70%)|
1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
|Duration (year-month-day)||from 2019-08-01 to 2020-01-31|
Take a look of project's partnership.
|1||MATRIKS BIYOTEKNOLOJI SANAYI VE TICARET LIMITED SIRKETI||TR (GOLBASI ANKARA)||coordinator||50˙000.00|
CandidaHunter is the latest diagnostic innovation of Matriks Biotek®, owing to its years of expertise on medical biotechnology. The company has already developed and commercialized many diagnostic kits distributed over 37 countries around the world. This time Matriks Biotek targets Candidiasis, a fungal infection affecting roughly a million of people each year, making it the 4th leading cause of hospital infections. The mortality rate of 40% associated with the disease shows there is still much to improve in antifungal therapy.
The Challenge The most crucial need in Candidiasis treatment is fast diagnosis. Blood culture is the gold standard assay for Candidiasis diagnosis but can only detect 50% of the cases within 3 to 5 days. Delayed treatment and undiagnosed cases lead to dissemination of the disease and cause severe infections in internal organs.
Our Solution Matriks Biotek introduces CandidaHunter as a fast blood culture medium to detect Candidiasis in bloodstream. Enhancing the golden standard with nanotechnology, CandidaHunter offers an increased detection sensitivity of 80% and a much shorter diagnosis period of 24 hours.
The Opportunity Factors like high incidence of infections, rising demand for fast diagnostic tests, aging population as well as advancements in medical technology always make newer and better solutions highly sought after. Considering its unique features, Matriks Biotek believes CandidaHunter will easily make a name for itself all around the world. Culture based technologies have the largest share in the diagnostic market due to the extensive usage of conventional blood culture media. By commercializing it on global scale, Matriks Biotek aims to benefit from CandidaHunter with its potential leverage effects and apply its capabilities to a new market.
Matriks Biotek is an R&D intensive SME established in 2002 with a main focus on therapeutic drug monitoring and immunogenicity detection.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CANDIDAHUNTER" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "CANDIDAHUNTER" are provided by the European Opendata Portal: CORDIS opendata.
First in the world ecological and sustainable cream for wound care, based on microalgaprasinococcus capsulatusRead More
FAST-RESPONSIVE and LONG-LASTING TRANSPARENT PHOTOCHROMIC FILMSRead More
Standardised administration device for raw medical herbsRead More